Science News
from research organizations

High risk of acute mountain sickness on Mount Kilimanjaro

Date:
October 11, 2010
Source:
Mary Ann Liebert, Inc./Genetic Engineering News
Summary:
Climbers of high peaks such as Mount Kilimanjaro are at high risk for acute mountain sickness (AMS). Trekkers should not ignore AMS warning signs, which can progress to more serious medical outcomes. Mountain climbers can best minimize their risk for altitude sickness by becoming acclimatized to increased altitudes before an ascent, according to a new study.
Share:
       
FULL STORY

High Altitude Medicine & Biology, the Official Journal of the International Society for Mountain Medicine, is an authoritative, peer-reviewed journal published quarterly online and is the only journal dedicated exclusively to the latest advances in high altitude life sciences. The Journal presents findings on the effects of chronic hypoxia on lung and heart disease, pulmonary and cerebral edema, hypertension, dehydration, infertility, appetite and weight loss, and other diseases.
Credit: © Mary Ann Liebert Inc.

Climbers of high peaks such as Mount Kilimanjaro are at high risk for Acute Mountain Sickness (AMS). Trekkers should not ignore AMS warning signs, which can progress to more serious medical outcomes. Mountain climbers can best minimize their risk for altitude sickness by becoming acclimatized to increased altitudes before an ascent, according to a study in the current issue of High Altitude Medicine & Biology, a peer-reviewed journal published by Mary Ann Liebert, Inc.

The study, entitled "Incidence and predictors of acute mountain sickness among trekkers on Mount Kilimanjaro," evaluated the incidence of AMS among trekkers of this popular climbing destination. Stewart Jackson, J. Kenneth Baillie, and colleagues from University of Edinburgh (Scotland) and Muhimbili University College of Health Science (Tanzania), compared the effects of three increasingly difficult and rapid ascent routes, the option of a single rest day during the climb, and use by a sub-group of climbers of prophylactic acetazolamide.

The authors reported a similar rate of AMS among climbers with or without prophylactic drug use. Furthermore, a mid-climb rest day did not affect the incidence of AMS. Only prior acclimatization to increased altitude offered a significant protective effect against AMS.

"This important article emphasizes the dangers of rapid ascent rates on a mountain that attracts thousands of visitors every year. Hopefully it will help to reduce the high frequency of high altitude diseases," says John B. West, MD, PhD, Editor-in-Chief of High Altitude Medicine & Biology and Professor of Medicine at the University of California, San Diego School of Medicine.


Story Source:

The above post is reprinted from materials provided by Mary Ann Liebert, Inc./Genetic Engineering News. Note: Materials may be edited for content and length.


Journal Reference:

  1. Stewart J. Jackson, James Varley, Claudia Sellers, Katherine Josephs, Lucy Codrington, Georgina Duke, Marina A. Njelekela, Gordon Drummond, Andrew I. Sutherland, A. A. Roger Thompson, J. Kenneth Baillie. Incidence and predictors of acute mountain sickness among trekkers on Mount Kilimanjaro. High Altitude Medicine & Biology, 2010; 11 (3): 217 DOI: 10.1089/ham.2010.1003

Cite This Page:

Mary Ann Liebert, Inc./Genetic Engineering News. "High risk of acute mountain sickness on Mount Kilimanjaro." ScienceDaily. ScienceDaily, 11 October 2010. <www.sciencedaily.com/releases/2010/10/101006131211.htm>.
Mary Ann Liebert, Inc./Genetic Engineering News. (2010, October 11). High risk of acute mountain sickness on Mount Kilimanjaro. ScienceDaily. Retrieved July 31, 2015 from www.sciencedaily.com/releases/2010/10/101006131211.htm
Mary Ann Liebert, Inc./Genetic Engineering News. "High risk of acute mountain sickness on Mount Kilimanjaro." ScienceDaily. www.sciencedaily.com/releases/2010/10/101006131211.htm (accessed July 31, 2015).

Share This Page: